MAXIMA ANTONIA BOKILIA, 051211131065 (2016) PROFIL PENGGUNAAN ANTITUBERKULOSIS PADA PASIEN AIDS ANAK RAWAT INAP (Penelitian dilakukan di RSUD Dr. Saiful Anwar Malang). Skripsi thesis, Universitas Airlangga.
|
Text (abstrak)
FF.FK. 23-16 Bok p abstrak.pdf Download (575kB) | Preview |
|
Text (fulltext)
FF.FK. 23-16 Bok p.pdf Restricted to Registered users only Download (1MB) | Request a copy |
Abstract
Backgrounds: People with AIDS have an increased risk of developing various bacterial infection such as Mycobacterium tuberculosis. Children with AIDS have a better oppurtunity to TB relapse than children who are not with AIDS. The appropriate management of HIV-associated TB in children remains extremely challenging due to diagnostic difficulties, multidrug resistant, the overlapping side effect profiles of anti-TB and ARV, the complexity of drug-drug interactions and IRIS after initiation of ARV. Objective: To analyze the profile of antituberculosis drugs used in tuberculosis infection with AIDS and to identify drug related problems (DRPs) of antituberculosis drug. Method: It was a retrospective study during period January 2013 to December 2015 in children with AIDS ages 0 to 14 years receiving anti tuberculosis. Result and Discussion: Dose antituberculosis in intensive phase is FDC (R 75 mg, H 50 mg, and Z 150 mg) (1 x 1, 2, 3 and 4 tabs) po, FDC (R 37 mg, H 37 mg, Z 111 mg) 1x¾ tab and FDC (R 90 mg, 60 mg H, Z 180 mg) 1x1,5 tab. Ethambutol dose is (1 x 110, 130, 200 and 400 mg) po. HES dose is H 1x145 mg, 1x360 mg E and S 1x300 mg IM. Doses intermediate phase is FDC (R 75 mg and H 50 mg. The problems that occur related to drugs is a side effect of H which causes numbness or tingling of hands and feet, RHZ cause hepatotoxicity and drug interactions of potential antituberculosis (R) and the anti-retroviral (evavirenz, nevirapine, zidovudine). Conclusion : Antituberculosis drugs use in children with AIDS were isoniazid, rifampicin, pyrazinamide, and ethambutol in combination. Route of administration of anti tuberculosis RHZE by oral and S by intramuscular. The dose in children were adjusted to the weight of patient. Keywords: Anti tuberculosis, Children with HIV, Tuberculosis
Item Type: | Thesis (Skripsi) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Additional Information: | KKB KK-2 FF.FK. 23-16 Bok p | |||||||||
Uncontrolled Keywords: | Anti tuberculosis, Children with HIV, Tuberculosis | |||||||||
Subjects: | R Medicine > RC Internal medicine > RC306-320.5 Tuberculosis R Medicine > RM Therapeutics. Pharmacology |
|||||||||
Divisions: | 05. Fakultas Farmasi > Farmasi Klinis | |||||||||
Creators: |
|
|||||||||
Contributors: |
|
|||||||||
Depositing User: | Tatik Poedjijarti | |||||||||
Date Deposited: | 19 Mar 2017 17:41 | |||||||||
Last Modified: | 19 Mar 2017 17:41 | |||||||||
URI: | http://repository.unair.ac.id/id/eprint/54851 | |||||||||
Sosial Share: | ||||||||||
Actions (login required)
View Item |